期刊文献+

肺癌组织中p53和VEGF的表达及其临床意义 被引量:1

下载PDF
导出
摘要 目的了解p53和血管内皮生长因子(vascular endothelial growth factor,VEGF)表达水平与肺癌临床病理特征之间的关系。方法采用免疫组化方法(二步法)检测220例肺癌组织中p53和VEGF的表达水平。结果 p53和VEGF的阳性表达率分别为48.6%和47.2%。p53和VEGF的表达水平与肺癌患者年龄、性别和组织学类型无相关性,P>0.05,与淋巴结转移、浸润和pTNM分期有关,P<0.05(P值分别为0.028、0.003和0.014),p53与原发肿瘤大小和癌细胞分化程度有关,P<0.05(P值分别为0.004和0.034),VEGF则与原发肿瘤大小和癌细胞分化程度无关,P>0.05(P值分别为0.798和0.686)。结论 p53和VEGF参与了肺癌的发生和发展过程,可以作为肺癌生物学水平的检测指标。
机构地区 吉林市中心医院
出处 《中国实用医药》 2010年第30期87-89,共3页 China Practical Medicine
  • 相关文献

参考文献15

  • 1沈诚,范士志,蒋耀光,陈建明,李志平.非小细胞肺癌微血管计数与血管内皮生长因子表达[J].中国肺癌杂志,2001,4(2):91-93. 被引量:13
  • 2Fontanini G;Calcinai A;Boldrini L.Modulation of neoan-giogenesis in bronchial preneoplastic lesions,1999(04).
  • 3Kakolyris S;Giatromanolaki A;Koulourakis M.Assessment of vascular maturation in non-small cell lung cancer using a novel base-ment membrane component,LH39:unrelation with and angiogenic factor expression[J],1999(21).
  • 4Zucker S;Mirza H;Conner C E.Vascular endot helial growth factor induces tissue factor and mat rix metalloproteinaseproduction in endot helial cells:conversion of prot hrombin to thrombin result s in progelatinase A activation and cell prolifera-tion,1998(05).
  • 5王慧敏,廖美琳,冯久贤,江晓丰,陈岗,朱大为.血管内皮生长因子对非小细胞肺癌术后生存率的影响[J].中国癌症杂志,2000,10(4):299-302. 被引量:13
  • 6赖百塘.血管内皮生长因子与肺癌,2001(03).
  • 7Anderson M L;Spandidos D A.Oncogenes and onCO2superssor genes in lung cancer,1993(06).
  • 8李印,车国卫,周清华,许金良.肺癌中血管内皮生长因子及突变型p53基因表达及其临床意义研究[J].中国肺癌杂志,2001,4(5):371-374. 被引量:19
  • 9Marchetti A;Buttitta F;Merlo G.P53 alteration in non-smallcell lung cancers correlate with metastatic involvement of hilar and me-diastinal lymphnodes,1993(12).
  • 10Niklinski J;Niklinska W;Chyczewski L.Molecular genetic abnormalities in premalignant lung lesions:biological and clinical implications[J],2001(03).

二级参考文献15

  • 1FlokmanJ.Whatistheevidencethattumorsareantiogenesisdependent[J]?JNatlCancerInst,1990,82(1):4-6.
  • 2MatsuyamaK,ChibaY,SasakiM,etal.Tumorangiogenesisasaprognosticmarkerinoperablenon-small-celllungcancer[J].AnnThoracSurg,1998,65(5):1405-1409.
  • 3WeidnerN.Intratmumormicrovesseldensityasaprogosticfactorincancer[J].AmJPathol,1995,147(1):9-19.
  • 4LeekA,HarrisL,LewisCE.Cytokinenetworksinsolidhumantumors:regulationofantiogenesis[J].JLeukocBiol,1994,56(4):423-435.
  • 5ImotoH,OsakiT,TageS,etal.Vascularendothelialgrowthfactorexpressioninnon-small-celllungcancer:prognosticsignificanceinsquamouscellcarcinoma[J].JThoracCardiovascSrug,1998,115(5):1007-1014.
  • 6VolmM,KoomagiR,MatternJ.PrognosticvalueofvascularendothelialgrowthfatoranditsreceptorFlt-1insquamouscelllungcancer[J].IntJCancer,(PredOncol),1997,74(1):64-68.
  • 7FontaniniG,VignatiS,BoldriniL,etal.Vascularendothelialgrowthfactorisassociatedwithneovascularizationandinfluencesprogressionofnon-small-celllungcarcinoma[J].ClinCancerRes,1997,3(6):861-865.
  • 8ChandrachudLM,PendletonN,ChisholmDM,etal.Relationshipbetweenvascularity,age,andsurvivalinnon-small-celllungcancer[J].BrJCancer,1997,76(10):1367-1375.
  • 9SengerDR,vandeWaterL,BrownLF,etal.Vascularpermeabilityfactor(VPF,VEGF)intumorbiology[J].CancerMetastasisRev,1993,12(3-4):303-324.
  • 10TanigawaN,AmayaH,MatsumuraM,etal.Correlationbetweenexpressionofvascularendothelialgrowthfactorandtumorvascularity,andpatientoutcomeinhumangastriccarcinoma[J].JCLinOncol,1997,15(2):826-832.

共引文献39

同被引文献3

  • 1Fontanini G,Boldrini L,Vignati S,et al.Bc12 and p53 regulate vascular endothelial growth factor (VEGF)-mediated angiogenesis in non-small cell lung carcinoma.Eur J Cancer,1998,34 (5):718-723.
  • 2Tong M,Lloyd B,Pei P,et al.Human head and neck squamous cell carcinoma cells are both targets and effectors for the angiogenic cytokine,VEGF.J Cell Biochem,2008,105(5):1202-1210.
  • 3席东焱,李玉明.抗血管内皮细胞生长因子(VEGF)靶向治疗在肺癌中的研究进展[J].天津医药,2009,37(6):524-526. 被引量:1

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部